| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.047 |
0.9 |
| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.9 |
| mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |